Despite low risk, there is an increased relative risk of carditis - a type of heart inflammation - associated with Covid vaccine developed by Pfizer and China's CoronaVac, researchers have found.
Albert Bourla has said Pfizer could be ready to file for approval for a redesigned vaccine to fight Omicron, and mass produce it, as soon as March
Those who have received the Moderna Covid-19 mRNA vaccine are less likely to experience "breakthrough" Covid-19 cases, compared to recipients of the Pfizer-BioNTech mRNA vaccine
A study has found that two doses of Sputnik V provide two times higher virus neutralising antibodies against the Omicron variant of COVID-19 than two doses of the Pfizer vaccine
The US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccine for children under 5 years of age in February, White House chief medical advisor Anthony Fauci has said.
Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy
Albert Bourla, chairman and chief executive of global pharmaceutical giant Pfizer Inc., was awarded the prestigious Genesis Prize for his efforts in leading the development of a Covid-19 vaccine
Health officials have described the Paxlovid pills as a potentially important tool to suppress hospitalisations and deaths
Rising cases of Covid-19 have unsettled the government. It recently approved two new vaccines. But, what is the difference between these vaccines? What platforms are used to develop them? Find out
At least 21,000 of Pfizer's antiviral pills, called Paxlovid, will arrive in South Korea on Thursday, with another 10,000 more expected to arrive by the end of the month, the health ministry said
Pfizer's vaccine that specifically targets the Omicron variant of Covid-19 will be ready in March, the pharmaceutical giant's CEO Albert Bourla has said
The announcement comes as countries in much of the 27-nation bloc are reporting soaring numbers of infections
The US's CDC said it expanded the eligibility of Pfizer Inc and BioNTech SE's booster doses to those 12 to 15 years old
The partners expect to start human trials of the new vaccine in the second half of this year, they said in a statement
To decrease hospitalisations and deaths from Covid, the US administration is going to double its order of Pfizer treatment courses, President Joe Biden said
The US FDA has expanded the emergency use authorisation for the Pfizer-BioNTech Covid-19 vaccine boosters to children aged 12 to 15.
The US is expanding Covid-19 boosters as it confronts the omicron surge, with the Food and Drug Administration allowing extra Pfizer shots for children as young as 12.
A team of US researchers has explored the success behind the new mRNA vaccine technology used by Pfizer and Moderna to make vaccines against Covid.
South Korea on Monday approved an emergency authorization of US drug giant Pfizer Inc.'s oral drug to treat Covid-19, making it the first such pill to be used in the country.
The United States has announced shipping an additional five million doses of Pfizer's coronavirus vaccine to Pakistan through the COVAX facility.